# Xylem Inc (XYL) — Stock CV

Xylem Inc is a $24.0B industrial company. Revenue grew 4.5% over the last year, it keeps 11¢ of every dollar of sales as profit, and it holds more cash than debt. It trades at 23.3× earnings — near the lowest of its own history.

> Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011.

## Identity

- **Ticker**: XYL
- **Sector**: Industrials
- **Industry**: Pumps & Pumping Equipment
- **Headquarters**: WASHINGTON, DC
- **Employees**: 22 000
- **Website**: https://www.xylem.com
- **Market cap**: $24.0B
- **Last price**: $102.71
- **Financial profile**: Mixed

## Vitals (TTM)

- **Revenue**: $9.13B
- **Net income**: $1.02B
- **Free cash flow**: $960M
- **Net cash**: $71.0M
- **P/E**: 23.3
- **Revenue growth (YoY)**: 4.5%

## Skills (profile scores, 0–100)

| Pillar | Score |
|---|---|
| Valuation | 69 |
| Growth | 95 |
| Profitability | 56 |
| Health | 68 |
| Quality | 89 |
| Moat | 56 |

## Qualifications (beginner checklist) — 9 of 11 passed

- [x] Revenue growing — +4.5% YoY
- [x] Profitable — $1.02B TTM
- [x] Profit growing — +26.0% YoY
- [x] Generates cash — $960M TTM
- [x] Debt under control — more cash than debt
- [x] Established company — $24.0B market cap
- [ ] Not printing shares — +34.7% shares over ~5y
- [x] Proven track record — 10/10 profitable years
- [ ] Financially stable — health score 43/100
- [x] Pays a dividend — yield 1.69%
- [x] Valuation not extreme — P/E 23.3

## Experience (career milestones)

- **FY2025** — Became debt-free: cash now exceeds total debt
- **FY2025** — Best year on record: $957M net income
- **2023** — Xylem completed the acquisition of Evoqua Water Technologies, a provider of water and wastewater…
- **FY2016** — Profitable every year on record: 10 consecutive profitable years in our data
- **FY2016** — Revenue already above $1B: $3.77B in first reported year
- **FY2016** — Positive free cash flow every year since: 10-year streak
- **2011** — Launched in 2011 as the spinoff of the water-related businesses of ITT Corporation, Xylem is headquartered in…
- **1996** — They then developed instrumentation for conductivity measurement of ultrapure water in 1996
- **1977** — They also continued developing thermal technology, with the first commercial gallium melting-point temperature…
- **1975** — They then developed further biomedical instrumentation: the first commercially successful whole blood glucose…
- **1972** — Their oxygen meter had used the technique of polarography, and they developed further products on the same…
- **1956** — First commercial heart-lung machine, in 1957, the first instantaneous blood-gas analyzer
- **1952** — The company from the start introduced the first commercial product in many categories: In 1952, they introduced the…
- **1947** — Sixten Englesson, chief engineer, invented the first submersible drainage pump in 1947 and the first submersible…
- **1872** — The Gould family ran the operation from 1872 until 1964, renaming the company Goulds Pumps Incorporated in 1926

## Strengths

- Net cash position after subtracting debt from cash
- Interest covered 132.2× by operating earnings
- Piotroski F-Score 7/9 — fundamentally strong checklist

## Watch-outs

- None stand out in the data.

## Track record

| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| FY2021 | $5.20B | $427M | $330M |
| FY2022 | $5.52B | $355M | $388M |
| FY2023 | $7.36B | $609M | $566M |
| FY2024 | $8.56B | $890M | $942M |
| FY2025 | $9.04B | $957M | $910M |

---

Source: https://stockcv.com/XYL — derived from company filings; may be delayed or incomplete. Information, not investment advice.